Skip to main content
Equibles

Erste Asset Management GmbH

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 2024532 VIENNA, C4
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$245,557
-$1,117,928 QoQ
Shares Held
23,566
-89.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 95 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. RNAC ranks #64 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AGIO
Agios Pharmaceuticals, Inc.
 2,154,900 $79,968,339
2 MDGL
Madrigal Pharmaceuticals, Inc.
 110,210 $59,177,259
3 SRPT
Sarepta Therapeutics, Inc.
 2,568,945 $46,163,941
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 76,558 $38,028,654
5 ROIV
Roivant Sciences Ltd.
 834,000 $29,515,260
6 DNA
Ginkgo Bioworks Holdings, Inc.
 2,536,939 $25,141,065
7 REGN
Regeneron Pharmaceuticals, Inc.
 38,716 $24,140,974
8 MIRM
Mirum Pharmaceuticals, Inc.
 205,000 $23,999,350

All Filings in RNAC

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,557 23,566
2026-03-31 $1,363,485 221,705
2025-12-31 $1,958,993 271,705
2025-09-30 $2,657,312 260,011
2025-06-30 $2,701,514 260,011
2025-03-31 $3,426,944 260,011
2024-12-31 $3,108,567 173,566
2024-09-30 $2,797,883 173,566
2024-06-30 $3,301,513 122,233
2024-03-31 $2,087,860 3,212,093
2023-12-31 $2,154,502 3,127,000
2023-09-30 $2,678,619 2,527,000
2023-06-30 $2,606,239 2,327,000
2023-03-31 $2,887,029 2,077,000
2022-12-31 $2,347,009 2,077,000
2022-09-30 $3,406,279 2,077,000
2022-06-30 $3,375,869 2,577,000
2022-03-31 $2,493,209 2,027,000
2021-12-31 $3,944,599 1,210,000